Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Operating Leases (2021 - 2025)

BioAtla (BCAB) has disclosed Operating Leases for 5 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • For Q4 2025, Operating Leases rose 639.77% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, up 639.77%, while the annual FY2025 figure was $1.3 million, 639.77% up from the prior year.
  • Operating Leases hit $1.3 million in Q4 2025 for BioAtla, down from $5.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $5.2 million in Q2 2025 and bottomed at $176000.0 in Q4 2024.
  • Average Operating Leases over 5 years is $2.1 million, with a median of $1.5 million recorded in 2023.
  • Year-over-year, Operating Leases tumbled 79.88% in 2024 and then skyrocketed 639.77% in 2025.
  • BioAtla's Operating Leases stood at $1.1 million in 2021, then decreased by 25.89% to $836000.0 in 2022, then changed by 0.0% to $836000.0 in 2023, then tumbled by 78.95% to $176000.0 in 2024, then surged by 639.77% to $1.3 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $1.3 million, $5.0 million, and $5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.